Skip to main content
PureTech Health plc logo

PureTech Health plc — Investor Relations & Filings

Ticker · PRTC ISIN · GB00BPVG5C82 LEI · 213800LVPDNO2Z9T9I39 IL Manufacturing
Open in API
Filings indexed 1,320 across all filing types
Latest filing 2022-05-17 Transaction in Own Shar…
Country GB United Kingdom
Listing IL PRTC

About PureTech Health plc

https://puretechhealth.com/

PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title section: 'Transaction in Own Shares'. It details the purchase of ordinary shares as part of a 'Share Buyback Programme' on a specific date (16 May 2022), including volume, high, low, and VWAP prices. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS), which covers company buying back or selling its own shares.
2022-05-17 English
PRTC Presents LYT-100 Data at ATS Conference
Regulatory Filings Classification · 99% confidence The document is identified by the header 'RNS Number' and contains a date (16 May 2022) and a headline announcing the presentation of clinical data ('PureTech Presents Additional Phase 1 Data for LYT-100 at American Thoracic Society 2022'). The text describes clinical trial results, future development plans (registration-enabling studies), and includes standard boilerplate sections like 'About LYT-100', 'About Idiopathic Pulmonary Fibrosis (IPF)', and 'Cautionary Note Regarding Forward-Looking Statements'. Crucially, it is distributed via RNS and mentions that the information is provided by 'Reach, the non-regulatory press release distribution service of RNS'. This structure strongly indicates a press release announcing scientific/clinical progress, which is typically classified as an Earnings Release (ER) if it contains financial highlights, or a general Regulatory Filing (RNS) if it's primarily operational/clinical news. Since this is a detailed announcement of clinical data presentation and future study plans, and not a formal financial report (like 10-K or IR) or a brief earnings highlight (ER), it fits best under the general regulatory announcement category, RNS, as it is a non-standard, non-financial-report regulatory update distributed through the RNS system.
2022-05-16 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states the subject as 'Transaction in Own Shares' and details the purchase of ordinary shares as part of a 'Share Buyback Programme'. It provides specific transaction dates, volumes, and prices. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The presence of the RNS header confirms it is a regulatory announcement, but the specific content points overwhelmingly to POS.
2022-05-16 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is titled 'Transaction in Own Shares' and explicitly details the purchase of ordinary shares by PureTech Health PLC as part of its 'Share Buyback Programme'. It provides specific transaction dates, volumes, and prices. This directly corresponds to the definition of a report detailing the company buying back or selling its own shares. Therefore, the correct classification is Transaction in Own Shares (POS).
2022-05-13 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an RNS announcement from PureTech Health PLC dated May 12, 2022. The title explicitly states 'Transaction in Own Shares' and the content details the purchase of ordinary shares as part of a 'Share Buyback Programme'. This directly corresponds to the definition of a company reporting the repurchase or sale of its own shares. Therefore, the appropriate filing type is 'Transaction in Own Shares' (POS).
2022-05-12 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is titled 'Transaction in Own Shares' and explicitly details the purchase of ordinary shares by PureTech Health PLC as part of its 'Share Buyback Programme'. It provides specific transaction data including date, volume, and price range. This directly corresponds to the definition of a report detailing the company buying back or selling its own shares. Therefore, the correct classification is Transaction in Own Shares (POS).
2022-05-11 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.